Oral Nanotherapeutics of Andrographolide/Carbon Monoxide Donor for Synergistically Anti-inflammatory and Pro-resolving Treatment of Ulcerative Colitis
ACS Applied Materials & Interfaces · 2023-08-02 · 15 (30) · 36061-36075
DOI: 10.1021/acsami.3c09342 ↗At a glance
Journal article in ACS Applied Materials & Interfaces, published online on 2023-07-18. Written by Ying Zhou and 9 co-authors. Institution: Second Clinical Medical College, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi 712046, China. Major MEDLINE topics: Colitis, Ulcerative. Cited 42 times so far (Crossref); 64 references. Funded by: Xi?an Jiaotong University, National Natural Science Foundation of China, Key Research and Development Projects of Shaanxi Province.
Abstract (original language)
Ulcerative colitis (UC) is a chronic inflammatory bowel disease of unknown etiology affecting the colon and rectum. Current therapeutics are focused on suppressing inflammation but are ineffective. Combining anti-inflammatory therapeutic approaches with pro-resolution might be a superior strategy for UC treatment. Andrographolide (AG), an active compound from the plant Andrographis paniculata, presented anti-inflammatory effects in various inflammatory diseases. Gaseous mediators, such as carbon monoxide (CO), have a role in inflammatory resolution. Herein, we developed a dextran-functionalized PLGA nanocarrier for efficient delivery of AG and a carbon monoxide donor (CORM-2) for synergistically anti-inflammatory/pro-resolving treatment of UC (AG/CORM-2@NP-Dex) based on PLGA with good biocompatibility, slow drug release, efficient targeting, and biodegradability. The resulting nanocarrier had a nano-scaled diameter of ∼200 nm and a spherical shape. After being coated with dextran (Dex), the resulting AG/CORM-2@NP-Dex could be efficiently internalized by Colon-26 and Raw 264.7 cells in vitro and preferentially localized to the inflamed colon with chitosan/alginate hydrogel protection by gavage. AG/CORM-2@NP-Dex performed anti-inflammatory effects by eliminating the over-production of pro-inflammatory mediator, nitric oxide (NO), and down-regulating the expression of pro-inflammatory cytokines (TNF-α, IL-1β and IL-6), while it showed pro-resolving function by accelerating M1 to M2 macrophage conversion and up-regulating resolution-related genes (IL-10, TGF-β, and HO-1). In the colitis model, oral administration of AG/CORM-2@NP-Dex in a chitosan/alginate hydrogel also showed synergistically anti-inflammatory/pro-resolving effects, therefore relieving UC effectively. Without appreciable systemic toxicity, this bifunctional nanocarrier represents a novel therapeutic approach for UC and is expected to achieve long-term inflammatory remission.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Second Clinical Medical College, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi 712046, China.
- Department of Pediatrics, Tangdu Hospital, Air Force Medical University, Xi'an 710032, China.
- Department of Thoracic Surgery, The First Affiliated Hospital of Xian Jiaotong University, Xi'an 710061, China.
- School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi 710061, China.
- Department of Anesthesiology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China.
- Department of Gastroenterology, The First Affiliated Hospital of Xi'an Medical University, Xi'an, Shaanxi 710077, China.
ORCID profiles: Mingzhen Zhang, Mingxin Zhang
Funding
- Xi?an Jiaotong University
- National Natural Science Foundation of China
- Key Research and Development Projects of Shaanxi Province
Cite
APA
Zhou, Y., Yang, M., Yan, X., Zhang, L., Lu, N., Ma, Y., Zhang, Y., Cui, M., Zhang, M., & Zhang, M. (2023). Oral Nanotherapeutics of Andrographolide/Carbon Monoxide Donor for Synergistically Anti-inflammatory and Pro-resolving Treatment of Ulcerative Colitis. ACS Applied Materials & Interfaces, 15(30), 36061-36075. https://doi.org/10.1021/acsami.3c09342
Vancouver
Zhou Y, Yang M, Yan X, Zhang L, Lu N, Ma Y, et al. Oral Nanotherapeutics of Andrographolide/Carbon Monoxide Donor for Synergistically Anti-inflammatory and Pro-resolving Treatment of Ulcerative Colitis. ACS Applied Materials & Interfaces. 2023;15(30):36061-36075. doi:10.1021/acsami.3c09342
BibTeX
@article{Zhou2023,
author = {Zhou, Ying and Yang, Mei and Yan, Xiangji and Zhang, Lingmin and Lu, Ning and Ma, Yana and Zhang, Yuanyuan and Cui, Manli and Zhang, Mingzhen and Zhang, Mingxin},
title = {Oral Nanotherapeutics of Andrographolide/Carbon Monoxide Donor for Synergistically Anti-inflammatory and Pro-resolving Treatment of Ulcerative Colitis},
journal = {ACS Applied Materials & Interfaces},
year = {2023},
volume = {15},
number = {30},
pages = {36061--36075},
doi = {10.1021/acsami.3c09342}
}
EUVIMED